Alemtuzumab’s impact on functional and structural integrity of the visual system in MS

Prof Michael Barnett, Director Sydney Neuroimaging Analysis Centre and Professor of Neurology, University of Sydney, joins JNNP's Podcast Editor, Colin Mahoney, to discuss how the use of Alemtuzumab may have longer-term impacts on improving one of the most commonly involved neurological pathways, the visual system, in multiple sclerosis (MS). Prof Barnett discusses his team's results after following up patients with highly active MS for 24 months, using multifocal visual evoked potentials and advanced neuroimaging. He also talks about what this means for future remyelination strategies. Related paper:

You can listen to Alemtuzumab’s impact on functional and structural integrity of the visual system in MS online on Radio and Podcast. Open the player on this page to stream the available audio.

Alemtuzumab’s impact on functional and structural integrity of the visual system in MS is an episode from JNNP podcast by BMJ Group.

This episode is 20:02 long.

This episode was published on Nov 17, 2021.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from JNNP podcast when more episodes are available from the podcast feed.